Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Plitidepsin

EU orphan designation number: EU/3/10/838
Active ingredient: Plitidepsin
Indication: Treatment of post-essential thrombocythaemia myelofibrosis
Sponsor: Pharma Mar S.A.
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/121/10 (2011)1304 of 23/02/2011
27/06/2011 Centralised Orphan - Removal of orphan designation from Community Register